Chronic hypoxia promotes an aggressive phenotype in rat prostate cancer cells

Free Radical Research

Volumn 41, Issue 7, 2007, Pages 788-797

  Alqawi, Oma ^a   Wang, Hong P ^a   Espiritu, Myrna ^a   Singh, Gurmit ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Chronic hypoxia; HIF 1 ; MMPs; NF B; VEGF

Indexed keywords

GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MATRIGEL; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CANCER CELL; CANCER GROWTH; CELL HYPOXIA; CELL INVASION; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; GENETIC TRANSFECTION; INCUBATION TIME; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PHENOTYPE; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN SECRETION; RADIATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL HYPOXIA; CELL SURVIVAL; GENES, REPORTER; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; NEOPLASM INVASIVENESS; NF-KAPPA B; PROSTATIC NEOPLASMS; RATS; TRANSFECTION; TUMOR CELLS, CULTURED;

RATTUS;

EID: 34347266205     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760701361531     Document Type: Article

References (46)

1. Suzuki, H., Tomida, A. and Tsuruo, T. (2001) Dephosphorylated hypoxia-inducible factor 1alpha as a mediator of p53-dependent apoptosis during hypoxia. Oncogene, 20, pp. 5779-5788.
2. Chen, J., Zhao, S., Nakada, K., Kuge, Y., Tamaki, N., Okada, F., Wang, J., Shindo, M., Higashino, F., Takeda, K., Asaka, M., Katoh, H., Sugiyama, T., Hosokawa, M. and Kobayashi, M. (2003) Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism. Am J Pathol, 162, pp. 1283-1291.
3. Sowter, HM, Ratcliffe, PJ, Watson, P., Greenberg, AH and Harris, AL (2001) HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res, 61, pp. 6669-6673.
4. Krishnamachary, B., Berg-Dixon, S., Kelly, B., Agani, F., Feldser, D., Ferreira, G., Iyer, N., LaRusch, J., Pak, B., Taghavi, P. and Semenza, GL (2003) Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res, 63, pp. 1138-1143.
5. Haddad, JJ, Olver, RE and Land, SC (2000) Antioxidant/pro-oxidant equilibrium regulates HIF-1alpha and NF-kappa B redox sensitivity. Evidence for inhibition by glutathione oxidation in alveolar epithelial cells. J Biol Chem, 275, pp. 21130-21139.
6. Michiels, C., Minet, E., Mottet, D. and Raes, M. (2002) Regulation of gene expression by oxygen: NF-kappaB and HIF-1, two extremes. Free Radic Biol Med, 33, pp. 1231-1242.
7. 2 sensing. J Biol Chem, 275, pp. 25130-25138.
8. Schmedtje Jr., JF, Ji, YS, Liu, WL, DuBois, RN and Runge, MS (1997) Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J Biol Chem, 272, pp. 601-608.
9. Koong, AC, Chen, EY, Mivechi, NF, Denko, NC, Stambrook, P. and Giaccia, AJ (1994) Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2). Cancer Res, 54, pp. 5273-5279.
10. 2-regulated prolyl hydroxylation. Science, 292, pp. 468-472.
11. 2 sensing. Science, 292, pp. 464-468.
12. Cockman, ME, Masson, N., Mole, DR, Jaakkola, P., Chang, GW, Clifford, SC, Maher, ER, Pugh, CW, Ratcliffe, PJ and Maxwell, PH (2000) Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J Biol Chem, 275, p. 25733.
13. Kamura, T., Sato, S., Iwai, K., Czyzyk-Krzeska, M., Conaway, RC and Conaway, JW (2000) Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc Natl Acad Sci USA, 97, pp. 10430-10435.
14. Tanimoto, K., Makino, Y., Pereira, T. and Poellinger, L. (2000) Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J, 19, pp. 4298-4309.
15. Ohh, M., Park, CW, Ivan, M., Hoffman, MA, Kim, TY, Huang, LE, Pavletich, N., Chau, V. and Kaelin, WG (2000) Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Biol, 2, pp. 423-427.
16. Verma, IM, Stevenson, JK, Schwarz, EM, Van Antwerp, D. and Miyamoto, S. (1995) Rel/NF-kappa B/I kappa B family: Intimate tales of association and dissociation. Genes Dev, 9, pp. 2723-2735.
17. Suzuki, Y., Nishio, K., Takeshita, K., Takeuchi, O., Watanabe, K., Sato, N., Naoki, K., Kudo, H., Aoki, T. and Yamaguchi, K. (2000) Effect of steroid on hyperoxia-induced ICAM-1 expression in pulmonary endothelial cells. Am J Physiol Lung Cell Mol Physiol, 278, pp. L245-L252.
18. Figueroa, YG, Chan, AK, Ibrahim, R., Tang, Y., Burow, ME, Alam, J., Scandurro, AB and Beckman, BS (2002) NF-kappaB plays a key role in hypoxia-inducible factor-1-regulated erythropoietin gene expression. Exp Hematol, 30, pp. 1419-1427.
19. Jung, YJ, Isaacs, JS, Lee, S., Trepel, J. and Neckers, L. (2003) Microtubule disruption utilizes an NFkappa B-dependent pathway to stabilize HIF-1alpha protein. J Biol Chem, 278, pp. 7445-7452.
20. Maxwell, PH, Dachs, GU, Gleadle, JM, Nicholls, LG, Harris, AL, Stratford, IJ, Hankinson, O., Pugh, CW and Ratcliffe, PJ (1997) Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci USA, 94, pp. 8104-8109.
21. Williams, KJ, Telfer, BA, Airley, RE, Peters, HP, Sheridan, MR, van der Kogel, AJ, Harris, AL and Stratford, IJ (2002) A protective role for HIF-1 in response to redox manipulation and glucose deprivation: Implications for tumorigenesis. Oncogene, 21, pp. 282-290.
22. Huang, S., Pettaway, CA, Uehara, H., Bucana, CD and Fidler, IJ (2001) Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene, 20, pp. 4188-4197.
23. Matrisian, LM (1990) Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet, 6, pp. 121-125.
24. Bernhard, EJ, Gruber, SB and Muschel, RJ (1994) Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc Natl Acad Sci USA, 91, pp. 4293-4297.
25. Wilson, MJ and Sinha, AA (1993) Plasminogen activator and metalloprotease activities of Du-145, PC-3, and 1-LN-PC-3-1A human prostate tumors grown in nude mice: Correlation with tumor invasive behavior. Cell Mol Biol Res, 39, pp. 751-760.
26. Quax, PH, de Bart, AC, Schalken, JA and Verheijen, JH (1997) Plasminogen activator and matrix metalloproteinase production and extracellular matrix degradation by rat prostate cancer cells in vitro: Correlation with metastatic behavior in vivo. Prostate, 32, pp. 196-204.
27. Stetler-Stevenson, WG (1990) Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev, 9, pp. 289-303.
28. Gum, R., Lengyel, E., Juarez, J., Chen, JH, Sato, H., Seiki, M. and Boyd, D. (1996) Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J Biol Chem, 271, pp. 10672-10680.
29. Singh, S., Sadacharan, S., Belldegrun, A., Persad, S. and Singh, G. (2003) Overexpression of vimentin: Role in the invasive phenotype in an androgen-independent model of prostate cancer. Cancer Res, 63, pp. 2306-2311.
30. Cazals, V., Nabeyrat, E., Corroyer, S., de Keyzer, Y. and Clement, A. (1999) Role for NF-kappa B in mediating the effects of hyperoxia on IGF-binding protein 2 promoter activity in lung alveolar epithelial cells. Biochim Biophys Acta, 1448, pp. 349-362.
31. Ebert, BL, Firth, JD and Ratcliffe, PJ (1995) Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences. J Biol Chem, 270, pp. 29083-29089.
32. Merrall, NW, Plevin, R. and Gould, GW (1993) Growth factors, mitogens, oncogenes and the regulation of glucose transport. Cell Signal, 5, pp. 667-675.
33. Forsythe, JA, Jiang, BH, Iyer, NV, Agani, F., Leung, SW, Koos, RD and Semenza, GL (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol, 16, pp. 4604-4613.
34. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol, 15, pp. 551-578.
35. Mottet, D., Dumont, V., Deccache, Y., Demazy, C., Ninane, N., Raes, M. and Michiels, C. (2003) Regulation of HIF-1alpha protein level during hypoxic conditions by the PI3K/AKT/GSK3beta pathway in HepG2 cells. J Biol Chem, 278, pp. 31277-31285.
36. Arsham, AM, Plas, DR, Thompson, CB and Simon, MC (2002) Phosphatidylinositol 3-kinase/Akt signaling is neither required for hypoxic stabilization of HIF-1 alpha nor sufficient for HIF-1-dependent target gene transcription. J Biol Chem, 277, pp. 15162-15170.
37. Sang, N., Stiehl, DP, Bohensky, J., Leshchinsky, I., Srinivas, V. and Caro, J. (2003) MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300. J Biol Chem, 278, pp. 14013-14019.
38. Minet, E., Arnould, T., Michel, G., Roland, I., Mottet, D., Raes, M., Remacle, J. and Michiels, C. (2000) ERK activation upon hypoxia: Involvement in HIF-1 activation. FEBS Lett, 468, pp. 53-58.
39. Jiang, BH, Rue, E., Wang, GL, Roe, R. and Semenza, GL (1996) Dimerization DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem, 271, pp. 17771-17778.
40. Ikeda, E., Achen, MG, Breier, G. and Risau, W. (1995) Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem, 270, pp. 19761-19766.
41. Levy, AP, Levy, NS and Goldberg, MA (1996) Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel Lindau protein. J Biol Chem, 271, pp. 25492-25497.
42. Schreck, R., Rieber, P. and Baeuerle, PA (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J, 10, pp. 2247-2258.
43. Srinivas, V., Leshchinsky, I., Sang, N., King, MP, Minchenko, A. and Caro, J. (2001) Oxygen sensing and HIF-1 activation does not require an active mitochondrial respiratory chain electron-transfer pathway. J Biol Chem, 276, pp. 21995-21998.
44. Isaacs, JT, Isaacs, WB, Feitz, WF and Scheres, J. (1986) Establishment and characterization of seven dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers. Prostate, 9, pp. 261-281.
45. Zhong, H., Agani, F., Baccala, AA, Laughner, E., Rioseco-Camacho, N., Isaacs, WB, Simons, JW and Semenza, GL (1998) Increased expression of hypoxia inducible factor-1alpha in rat and human prostate cancer. Cancer Res, 58, pp. 5280-5284.
46. Himelstein, BP and Koch, CJ (1998) Studies of type IV collagenase regulation by hypoxia. Cancer Lett, 124, pp. 127-133.